Global Dystrophin Market Professional Survey Report 2019
Table of Contents
Executive Summary
1 Industry Overview of Dystrophin
- 1.1 Definition of Dystrophin
- 1.2 Dystrophin Segment by Type
- 1.2.1 Global Dystrophin Production Growth Rate Comparison by Types (2014-2025)
- 1.2.2 DS-5141
- 1.2.3 Biostrophin
- 1.2.4 BMBD-001
- 1.2.5 NS-065
- 1.2.6 Others
- 1.3 Dystrophin Segment by Applications
- 1.3.1 Global Dystrophin Consumption Comparison by Applications (2014-2025)
- 1.3.2 Genetic Disorders
- 1.3.3 Musculoskeletal Disorders
- 1.3.4 Others
- 1.4 Global Dystrophin Overall Market
- 1.4.1 Global Dystrophin Revenue (2014-2025)
- 1.4.2 Global Dystrophin Production (2014-2025)
- 1.4.3 North America Dystrophin Status and Prospect (2014-2025)
- 1.4.4 Europe Dystrophin Status and Prospect (2014-2025)
- 1.4.5 China Dystrophin Status and Prospect (2014-2025)
- 1.4.6 Japan Dystrophin Status and Prospect (2014-2025)
- 1.4.7 Southeast Asia Dystrophin Status and Prospect (2014-2025)
- 1.4.8 India Dystrophin Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
- 2.1 Raw Material and Suppliers
- 2.2 Manufacturing Cost Structure Analysis of Dystrophin
- 2.3 Manufacturing Process Analysis of Dystrophin
- 2.4 Industry Chain Structure of Dystrophin
3 Development and Manufacturing Plants Analysis of Dystrophin
- 3.1 Capacity and Commercial Production Date
- 3.2 Global Dystrophin Manufacturing Plants Distribution
- 3.3 Major Manufacturers Technology Source and Market Position of Dystrophin
- 3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
- 4.1 Dystrophin Production and Capacity Analysis
- 4.2 Dystrophin Revenue Analysis
- 4.3 Dystrophin Price Analysis
- 4.4 Market Concentration Degree
5 Dystrophin Regional Market Analysis
- 5.1 Dystrophin Production by Regions
- 5.1.1 Global Dystrophin Production by Regions
- 5.1.2 Global Dystrophin Revenue by Regions
- 5.2 Dystrophin Consumption by Regions
- 5.3 North America Dystrophin Market Analysis
- 5.3.1 North America Dystrophin Production
- 5.3.2 North America Dystrophin Revenue
- 5.3.3 Key Manufacturers in North America
- 5.3.4 North America Dystrophin Import and Export
- 5.4 Europe Dystrophin Market Analysis
- 5.4.1 Europe Dystrophin Production
- 5.4.2 Europe Dystrophin Revenue
- 5.4.3 Key Manufacturers in Europe
- 5.4.4 Europe Dystrophin Import and Export
- 5.5 China Dystrophin Market Analysis
- 5.5.1 China Dystrophin Production
- 5.5.2 China Dystrophin Revenue
- 5.5.3 Key Manufacturers in China
- 5.5.4 China Dystrophin Import and Export
- 5.6 Japan Dystrophin Market Analysis
- 5.6.1 Japan Dystrophin Production
- 5.6.2 Japan Dystrophin Revenue
- 5.6.3 Key Manufacturers in Japan
- 5.6.4 Japan Dystrophin Import and Export
- 5.7 Southeast Asia Dystrophin Market Analysis
- 5.7.1 Southeast Asia Dystrophin Production
- 5.7.2 Southeast Asia Dystrophin Revenue
- 5.7.3 Key Manufacturers in Southeast Asia
- 5.7.4 Southeast Asia Dystrophin Import and Export
- 5.8 India Dystrophin Market Analysis
- 5.8.1 India Dystrophin Production
- 5.8.2 India Dystrophin Revenue
- 5.8.3 Key Manufacturers in India
- 5.8.4 India Dystrophin Import and Export
6 Dystrophin Segment Market Analysis (by Type)
- 6.1 Global Dystrophin Production by Type
- 6.2 Global Dystrophin Revenue by Type
- 6.3 Dystrophin Price by Type
7 Dystrophin Segment Market Analysis (by Application)
- 7.1 Global Dystrophin Consumption by Application
- 7.2 Global Dystrophin Consumption Market Share by Application (2014-2019)
8 Dystrophin Major Manufacturers Analysis
- 8.1 Asklepios BioPharmaceutical Inc
- 8.1.1 Asklepios BioPharmaceutical Inc Dystrophin Production Sites and Area Served
- 8.1.2 Asklepios BioPharmaceutical Inc Product Introduction, Application and Specification
- 8.1.3 Asklepios BioPharmaceutical Inc Dystrophin Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.1.4 Main Business and Markets Served
- 8.2 BioMarin Pharmaceutical Inc
- 8.2.1 BioMarin Pharmaceutical Inc Dystrophin Production Sites and Area Served
- 8.2.2 BioMarin Pharmaceutical Inc Product Introduction, Application and Specification
- 8.2.3 BioMarin Pharmaceutical Inc Dystrophin Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.2.4 Main Business and Markets Served
- 8.3 Daiichi Sankyo Company Ltd
- 8.3.1 Daiichi Sankyo Company Ltd Dystrophin Production Sites and Area Served
- 8.3.2 Daiichi Sankyo Company Ltd Product Introduction, Application and Specification
- 8.3.3 Daiichi Sankyo Company Ltd Dystrophin Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.3.4 Main Business and Markets Served
- 8.4 Editas Medicine Inc
- 8.4.1 Editas Medicine Inc Dystrophin Production Sites and Area Served
- 8.4.2 Editas Medicine Inc Product Introduction, Application and Specification
- 8.4.3 Editas Medicine Inc Dystrophin Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.4.4 Main Business and Markets Served
- 8.5 Genethon SA
- 8.5.1 Genethon SA Dystrophin Production Sites and Area Served
- 8.5.2 Genethon SA Product Introduction, Application and Specification
- 8.5.3 Genethon SA Dystrophin Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.5.4 Main Business and Markets Served
- 8.6 Nippon Shinyaku Co Ltd
- 8.6.1 Nippon Shinyaku Co Ltd Dystrophin Production Sites and Area Served
- 8.6.2 Nippon Shinyaku Co Ltd Product Introduction, Application and Specification
- 8.6.3 Nippon Shinyaku Co Ltd Dystrophin Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.6.4 Main Business and Markets Served
- 8.7 Pfizer Inc
- 8.7.1 Pfizer Inc Dystrophin Production Sites and Area Served
- 8.7.2 Pfizer Inc Product Introduction, Application and Specification
- 8.7.3 Pfizer Inc Dystrophin Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.7.4 Main Business and Markets Served
- 8.8 Sarepta Therapeutics Inc
- 8.8.1 Sarepta Therapeutics Inc Dystrophin Production Sites and Area Served
- 8.8.2 Sarepta Therapeutics Inc Product Introduction, Application and Specification
- 8.8.3 Sarepta Therapeutics Inc Dystrophin Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.8.4 Main Business and Markets Served
- 8.9 WAVE Life Sciences Ltd
- 8.9.1 WAVE Life Sciences Ltd Dystrophin Production Sites and Area Served
- 8.9.2 WAVE Life Sciences Ltd Product Introduction, Application and Specification
- 8.9.3 WAVE Life Sciences Ltd Dystrophin Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.9.4 Main Business and Markets Served
9 Development Trend of Analysis of Dystrophin Market
- 9.1 Global Dystrophin Market Trend Analysis
- 9.1.1 Global Dystrophin Market Size (Volume and Value) Forecast 2019-2025
- 9.2 Dystrophin Regional Market Trend
- 9.2.1 North America Dystrophin Forecast 2019-2025
- 9.2.2 Europe Dystrophin Forecast 2019-2025
- 9.2.3 China Dystrophin Forecast 2019-2025
- 9.2.4 Japan Dystrophin Forecast 2019-2025
- 9.2.5 Southeast Asia Dystrophin Forecast 2019-2025
- 9.2.6 India Dystrophin Forecast 2019-2025
- 9.3 Dystrophin Market Trend (Product Type)
- 9.4 Dystrophin Market Trend (Application)
- 10.1 Marketing Channel
- 10.1.1 Direct Marketing
- 10.1.2 Indirect Marketing
- 10.3 Dystrophin Customers
11 Market Dynamics
- 11.1 Market Trends
- 11.2 Opportunities
- 11.3 Market Drivers
- 11.4 Challenges
- 11.5 Influence Factors
12 Conclusion
13 Appendix
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
The global Dystrophin market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Dystrophin volume and value at global level, regional level and company level. From a global perspective, this report represents overall Dystrophin market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Dystrophin in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Dystrophin manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Asklepios BioPharmaceutical Inc
BioMarin Pharmaceutical Inc
Daiichi Sankyo Company Ltd
Editas Medicine Inc
Genethon SA
Nippon Shinyaku Co Ltd
Pfizer Inc
Sarepta Therapeutics Inc
WAVE Life Sciences Ltd
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
DS-5141
Biostrophin
BMBD-001
NS-065
Others
Segment by Application
Genetic Disorders
Musculoskeletal Disorders
Others